- $210.02m
- $180.17m
- $4.06m
Annual balance sheet for Ocugen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 24 | 95 | 90.9 | 39.5 | 58.5 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 25.9 | 103 | 98.5 | 43 | 61.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.07 | 2.75 | 9.96 | 21.2 | 20.2 |
Other Long Term Assets | |||||
Total Assets | 27.4 | 106 | 109 | 64.5 | 82.4 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.61 | 7 | 18.5 | 17.1 | 21.6 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 5.83 | 9.94 | 24.6 | 24 | 52.8 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 21.6 | 95.8 | 84.1 | 40.6 | 29.6 |
Total Liabilities & Shareholders' Equity | 27.4 | 106 | 109 | 64.5 | 82.4 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |